Interview with CEO of InVivo Therapeutics

Posted on: March 12, 2012 Categorized in: Research

Frank Reynolds, CEO of Invivo Therapeutics talks about Invivo’s work with scaffolding and stem cells and plans for clinical trials.

Watch video on Fox2Now.com

SpinalCure to secure over $400,000 as Hearts & Minds Investments beneficiary partner

Media release: April 2024 ‘Impact investment’ for the future: SpinalCure Australia to secure over $400,000 as Hearts & Minds Investments beneficiary partner Generous philanthropic funding to be injected into cure-focused SCI research, representing a solid investment for…

New study unlocks vital clues about the immune system’s response to spinal cord injury

A new study published in the Journal of Neuroinflammation, by Professor Marc Ruitenberg and his research team at The University of Queensland, has yielded important insights about the effect of a spinal cord injury (SCI) on the body’s immune system,…

Advancing Spinal Cord Injury Research: Introducing the I. Peter Farrell SpinalCure Fellowship

By Duncan Wallace, Exec Director SpinalCure As someone who lives with a spinal cord injury (SCI), I know first-hand the impact it causes. Having an SCI casts a long shadow, devastating lives and leaving families grappling with profound emotional and…

In Memory of Bob Turner

BOB TURNER AM (1937-2024) It is with heavy hearts that we announce the passing of Bob Turner, a dedicated advocate and fundraiser for spinal injury funds. Bob Turner served as SCA’s (Hon) CEO and later as Chair, leaving a lasting…

Bowels, bladders and sex: addressing the stigma after an SCI

Issues with bowels, bladder and sex are often taboo for those living with a spinal cord injury (SCI) and not really thought about by those that aren’t. Inspired by a BBC Article with a personal account by Niall McCann here,…

Introduction

Interview with CEO of InVivo Therapeutics